# OnKure Therapeutics, Inc.: Form SC 13D/A, filed Oct 8, 2024

- Company: [OnKure Therapeutics, Inc.](/companies/okur.md) (CIK 1637715)
- Form: SC 13D/A
- Filed: 2024-10-08
- Accepted by EDGAR: Oct 8, 2024, 19:34 ET
- Period: not reported
- Accession: 0001072613-24-000769
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1637715/000107261324000769/nea15-onkure_18889.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1637715/000107261324000769/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1637715/000107261324000769/nea15-onkure_18889.htm

Filed Oct 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001072613-24-000769. Last ingested by Listed: Nov 4, 2026, 17:06 ET. No prices; not investment advice.